UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (611) 611
humans (586) 586
life sciences & biomedicine (584) 584
topotecan (499) 499
oncology (440) 440
female (389) 389
biological and medical sciences (346) 346
medical sciences (345) 345
topotecan - administration & dosage (308) 308
pharmacology. drug treatments (296) 296
antineoplastic agents (295) 295
chemotherapy (295) 295
male (288) 288
topotecan - pharmacokinetics (270) 270
adult (219) 219
middle aged (216) 216
aged (202) 202
animals (201) 201
antineoplastic agents - pharmacokinetics (199) 199
pharmacology & pharmacy (180) 180
antineoplastic combined chemotherapy protocols - therapeutic use (151) 151
topotecan - adverse effects (151) 151
topotecan - therapeutic use (145) 145
cancer (142) 142
antineoplastic agents - administration & dosage (140) 140
antineoplastic agents - therapeutic use (136) 136
camptothecin - analogs & derivatives (132) 132
neoplasms - drug therapy (131) 131
tumors (129) 129
mice (122) 122
drug administration schedule (115) 115
pharmacokinetics (115) 115
dose-response relationship, drug (104) 104
topotecan - pharmacology (104) 104
treatment outcome (98) 98
antineoplastic agents - adverse effects (97) 97
child (89) 89
infusions, intravenous (84) 84
ovarian neoplasms - drug therapy (84) 84
antineoplastic agents - pharmacology (81) 81
adolescent (80) 80
medicine & public health (78) 78
antineoplastic combined chemotherapy protocols - adverse effects (77) 77
child, preschool (77) 77
topoisomerase i inhibitors (77) 77
camptothecin - pharmacokinetics (74) 74
cell line, tumor (72) 72
lung neoplasms - drug therapy (72) 72
administration, oral (71) 71
antineoplastic combined chemotherapy protocols - administration & dosage (63) 63
care and treatment (63) 63
ovarian cancer (62) 62
drug resistance, neoplasm (61) 61
toxicity (61) 61
pharmacology/toxicology (58) 58
research (57) 57
irinotecan (55) 55
camptothecin - therapeutic use (54) 54
antineoplastic combined chemotherapy protocols - pharmacokinetics (52) 52
area under curve (52) 52
camptothecin (52) 52
neoplasm recurrence, local - drug therapy (51) 51
antimitotic agents (50) 50
hematology (50) 50
analysis (48) 48
drug therapy (48) 48
maximum tolerated dose (48) 48
physical sciences (48) 48
camptothecin - administration & dosage (47) 47
camptothecin - pharmacology (47) 47
chemistry (47) 47
atp binding cassette transporter, sub-family g, member 2 (46) 46
neoplasms - metabolism (46) 46
infant (45) 45
pediatrics (43) 43
topotecan - blood (42) 42
brain neoplasms - drug therapy (41) 41
clinical trials (41) 41
survival rate (41) 41
pharmacology (39) 39
rats (39) 39
cancer therapies (38) 38
carboplatin (37) 37
carcinoma, small cell - drug therapy (37) 37
endocrine system diseases (37) 37
carboplatin - administration & dosage (36) 36
neutropenia - chemically induced (36) 36
camptothecin - adverse effects (35) 35
mice, nude (35) 35
topoisomerase i inhibitors - administration & dosage (35) 35
aged, 80 and over (34) 34
cisplatin (34) 34
cisplatin - administration & dosage (34) 34
tumor cells, cultured (34) 34
lung cancer (33) 33
drug resistance (32) 32
etoposide - administration & dosage (32) 32
liposomes (32) 32
models, biological (32) 32
neuroblastoma (32) 32
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2003, Volume 42, Issue 14, 30
Melphalan, pharmacokinetics | Vinblastine, pharmacokinetics | Cytarabine, pharmacokinetics | Antimetabolites, pharmacokinetics | Gemcitabine, pharmacodynamics | Vinca alkaloids, pharmacodynamics | Fluorouracil, pharmacokinetics | Ifosfamide, pharmacodynamics | Methotrexate, pharmacokinetics | Topotecan, pharmacodynamics | Capecitabine, pharmacodynamics | Irinotecan, pharmacokinetics | Vinca alkaloids, pharmacokinetics | Alkylating agents, pharmacokinetics | Chlorambucil, pharmacokinetics | Cyclophosphamide, pharmacodynamics | Vincristine, pharmacokinetics | Carboplatin, pharmacodynamics | Fludarabine, pharmacodynamics | Cisplatin, pharmacokinetics | Vinorelbine, pharmacodynamics | Capecitabine, pharmacokinetics | Platinum complexes, pharmacokinetics | Topotecan, pharmacokinetics | Cytarabine, pharmacodynamics | DNA topoisomerase inhibitors, pharmacodynamics | Chlorambucil, pharmacodynamics | Fluorouracil, pharmacodynamics | Fludarabine, pharmacokinetics | Cyclophosphamide, pharmacokinetics | Antimetabolites, pharmacodynamics | Gemcitabine, pharmacokinetics | Melphalan, pharmacodynamics | Oxaliplatin, pharmacokinetics | Vinblastine, pharmacodynamics | Vinorelbine, pharmacokinetics | Cisplatin, pharmacodynamics | Vincristine, pharmacodynamics | Oxaliplatin, pharmacodynamics | Irinotecan, pharmacodynamics | Ifosfamide, pharmacokinetics | Methotrexate, pharmacodynamics | Alkylating agents, pharmacodynamics | Platinum complexes, pharmacodynamics | Carboplatin, pharmacokinetics | Elderly | DNA topoisomerase inhibitors, pharmacokinetics | Cancer | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Chemotherapy | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Drug Interactions | Antineoplastic Agents - adverse effects | Humans | Aged, 80 and over | Aging | Aged | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Frail Elderly | Patient Compliance | Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Index Medicus
Book Review
11/2000, Volume 39, Issue 5, 23
Book Review
Current medicinal chemistry, ISSN 0929-8673, 01/2017, Volume 24, Issue 2, pp. 193 - 214
Journal Article
Journal Article